# Evaluation of cfDNA as a Marker of Response in Rectal Cancer

> **NCT04319354** · NA · COMPLETED · sponsor: **Hospital Pedro Hispano** · enrollment: 50 (actual)

## Conditions studied

- Cancer of Rectum

## Interventions

- **DIAGNOSTIC_TEST:** Analysis of cfDNA

## Key facts

- **NCT ID:** NCT04319354
- **Lead sponsor:** Hospital Pedro Hispano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04319354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04319354, "Evaluation of cfDNA as a Marker of Response in Rectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04319354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*